TGFB1 and neoplasm: ART derivatives artesunate (ARS) and dihydroartemisinin (DHA) could reverse L-929 breast cancer cell-CAFs from activated to inactivated state through inhibition of TGF-β signaling, which resulted in a disruption of the interaction between tumor and TME.